Cargando…
Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563164/ https://www.ncbi.nlm.nih.gov/pubmed/32962118 http://dx.doi.org/10.3390/cancers12092673 |
| _version_ | 1783595429447860224 |
|---|---|
| author | Macek Jilkova, Zuzana Aspord, Caroline Decaens, Thomas |
| author_facet | Macek Jilkova, Zuzana Aspord, Caroline Decaens, Thomas |
| author_sort | Macek Jilkova, Zuzana |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7563164 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75631642020-10-27 Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554 Macek Jilkova, Zuzana Aspord, Caroline Decaens, Thomas Cancers (Basel) Reply MDPI 2020-09-18 /pmc/articles/PMC7563164/ /pubmed/32962118 http://dx.doi.org/10.3390/cancers12092673 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Reply Macek Jilkova, Zuzana Aspord, Caroline Decaens, Thomas Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554 |
| title | Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554 |
| title_full | Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554 |
| title_fullStr | Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554 |
| title_full_unstemmed | Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554 |
| title_short | Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554 |
| title_sort | reply to comment on “jilkova, z.m.; et al. predictive factors for response to pd-1/pd-l1 checkpoint inhibition in the field of hepatocellular carcinoma: current status and challenges” cancers 2019, 11, 1554 |
| topic | Reply |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563164/ https://www.ncbi.nlm.nih.gov/pubmed/32962118 http://dx.doi.org/10.3390/cancers12092673 |
| work_keys_str_mv | AT macekjilkovazuzana replytocommentonjilkovazmetalpredictivefactorsforresponsetopd1pdl1checkpointinhibitioninthefieldofhepatocellularcarcinomacurrentstatusandchallengescancers2019111554 AT aspordcaroline replytocommentonjilkovazmetalpredictivefactorsforresponsetopd1pdl1checkpointinhibitioninthefieldofhepatocellularcarcinomacurrentstatusandchallengescancers2019111554 AT decaensthomas replytocommentonjilkovazmetalpredictivefactorsforresponsetopd1pdl1checkpointinhibitioninthefieldofhepatocellularcarcinomacurrentstatusandchallengescancers2019111554 |